Raptiva, which has the generic name efalizumab, is a prescription medication used to treat moderate to severe psoriasis. Raptiva is administered as an injection once a week and may be injected into the thigh, abdomen, upper arm, or buttocks. Manufactured by Genentech Inc., Raptiva has been on the market since it received FDA approval in 2003.
Raptiva & Psoriasis Treatment
Psoriasis is a chronic skin condition involving the abnormal growth of new skin cells in patches called plaques, resulting in scaling and inflammation of the skin. Raptiva, which is known as an immunosuppressant, works by blocking the immune cells that cause these psoriasis plaques to develop.
Important Info about Raptiva
- Raptiva Side Effects
- Raptiva Black Box Warning
- Raptiva Infections
- Raptiva Lawyers
- Raptive & PML
- Raptiva Deaths
Dangerous Product Alert
- fever or chills
- sore throat
- redness, pain, or swelling of a skin wound
- burning or difficult urination
Raptiva may also cause a decreased number of platelets in the blood, which could result in bleeding. Raptiva patients should contact a doctor immediately if they display symptoms of low platelets, such as:
- unusual bruising or bleeding
- pinpoint red spots under the skin
- easy bleeding from the gums
- black, bloody or tarry stools
For some people, Raptiva may actually cause new or worsening cases of psoriasis. Raptiva patients who develop a rash, skin condition, or worsening psoriasis during treatment with Raptiva should contact a doctor.
Raptiva Side Effects Attorneys
On October 16, 2008, the FDA ordered Genentech to add a black box warning to the Raptiva label about Raptiva’s association with serious infections, including the deadly brain disease progressive multifocal leukoencephalopathy (PML). During its short time on the market, Raptiva has been linked to several serious side effects, including pneumonia, meningitis and cancer.
If you or a family member developed serious side effects after using Raptiva, you may be entitled to compensation for your injuries. Contact us today for a free and confidential case evaluation.